STOCKWATCH: Pfizer, Merck, Novartis look to shrink now, grow later
This article was originally published in Scrip
Executive Summary
Pfizer, Merck & Co, Novartis and other big drug makers are attempting to answer a nagging question: Do they need to get smaller in order to grow?